Prognosis in HR-positive Metastatic Breast Cancer with HER2-low Versus HER2-zero Treated with CDK4/6 Inhibitor and Endocrine Therapy: a Meta-Analysis
FRONTIERS IN ONCOLOGY（2024）
Key words
breast cancer,HER2-low,CDK4/6 inhibitor,endocrine therapy,prognosis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined